Masatoshi Ogata

429 total citations
28 papers, 295 citations indexed

About

Masatoshi Ogata is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Masatoshi Ogata has authored 28 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Masatoshi Ogata's work include Hormonal Regulation and Hypertension (12 papers), Adrenal and Paraganglionic Tumors (11 papers) and Adrenal Hormones and Disorders (10 papers). Masatoshi Ogata is often cited by papers focused on Hormonal Regulation and Hypertension (12 papers), Adrenal and Paraganglionic Tumors (11 papers) and Adrenal Hormones and Disorders (10 papers). Masatoshi Ogata collaborates with scholars based in Japan and United Kingdom. Masatoshi Ogata's co-authors include Yoshihiro Ogawa, Ryuichi Sakamoto, Yayoi Matsuda, Hironobu Umakoshi, Maki Yokomoto‐Umakoshi, Takashi Miyazawa, Hiromi Nagata, Masanori Kuratsune, Masato Ikeda and Seiichi Yano and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Masatoshi Ogata

27 papers receiving 294 citations

Peers

Masatoshi Ogata

EDM

SURGE

ONCOL

PHYSI

Sarah Nadeem Pakistan

Hyun Jin Oh South Korea

Sara Pinto France

Moeber Mahzari Saudi Arabia

Arun Upadhyaya China

Harit Buch United Kingdom

Kenji Iwaku Japan

Dominika Januś Poland

Mehmet Sargın Türkiye

Fumi Kikuchi Japan

Sarah Nadeem Pakistan

Masatoshi Ogata

255 ×1.9

EDM

177 ×1.9

SURGE

70 ×1.1

ONCOL

54 ×1.6

34 ×1.2

PHYSI

Citations per year, relative to Masatoshi Ogata Masatoshi Ogata (= 1×) peers Sarah Nadeem

Countries citing papers authored by Masatoshi Ogata

Since Specialization

Citations

This map shows the geographic impact of Masatoshi Ogata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Ogata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Ogata more than expected).

Fields of papers citing papers by Masatoshi Ogata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masatoshi Ogata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Ogata. The network helps show where Masatoshi Ogata may publish in the future.

Co-authorship network of co-authors of Masatoshi Ogata

This figure shows the co-authorship network connecting the top 25 collaborators of Masatoshi Ogata. A scholar is included among the top collaborators of Masatoshi Ogata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masatoshi Ogata. Masatoshi Ogata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakao, Hiroshi, Maki Yokomoto‐Umakoshi, Hironobu Umakoshi, et al.. (2023). Adrenal steroid metabolites and bone status in patients with adrenal incidentalomas and hypercortisolism. EBioMedicine. 95. 104733–104733. 10 indexed citations

Umakoshi, Hironobu, Norio Wada, Takamasa Ichijo, et al.. (2022). Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?. Clinical Endocrinology. 98(4). 473–480. 1 indexed citations

Yokomoto‐Umakoshi, Maki, Hironobu Umakoshi, Seiichi Yano, et al.. (2022). Coexistence of bone and vascular disturbances in patients with endogenous glucocorticoid excess. Bone Reports. 17. 101610–101610. 8 indexed citations

Umakoshi, Hironobu, Masatoshi Ogata, Hiroki Kaneko, et al.. (2022). Whole Transcriptome Profiling of Adrenocortical Tumors Using Formalin-Fixed Paraffin-Embedded Samples. Frontiers in Endocrinology. 13. 808331–808331. 2 indexed citations

Yokomoto‐Umakoshi, Maki, Hironobu Umakoshi, Seiichi Yano, et al.. (2022). Coexistence of Bone and Vascular Disturbances in Patients with Endogenous Glucocorticoid Excess. SSRN Electronic Journal.

Yokomoto‐Umakoshi, Maki, Hironobu Umakoshi, Yayoi Matsuda, et al.. (2021). Impact of Cortisol on Reduction in Muscle Strength and Mass: A Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism. 107(4). e1477–e1487. 26 indexed citations

Yokomoto‐Umakoshi, Maki, Hironobu Umakoshi, Yayoi Matsuda, et al.. (2021). Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk. The Journal of Clinical Endocrinology & Metabolism. 106(11). e4580–e4592. 13 indexed citations

Umakoshi, Hironobu, Masatoshi Ogata, Norio Wada, et al.. (2021). Machine learning based models for prediction of subtype diagnosis of primary aldosteronism using blood test. Scientific Reports. 11(1). 9140–9140. 19 indexed citations

Umakoshi, Hironobu, Masatoshi Ogata, Maki Yokomoto‐Umakoshi, et al.. (2020). Significance of Discordant Results Between Confirmatory Tests in Diagnosis of Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 106(2). e866–e874. 13 indexed citations

10.

Ogata, Masatoshi, Hironobu Umakoshi, Yayoi Matsuda, et al.. (2020). Significance of aldosterone gradient within left adrenal vein in diagnosing unilateral subtype of primary aldosteronism. Clinical Endocrinology. 94(1). 24–33. 3 indexed citations

11.

Yano, Seiichi, Kenji Ashida, Ryuichi Sakamoto, et al.. (2020). Human leucocyte antigen DR15, a possible predictive marker for immune checkpoint inhibitor–induced secondary adrenal insufficiency. European Journal of Cancer. 130. 198–203. 65 indexed citations

12.

Yokomoto‐Umakoshi, Maki, Hironobu Umakoshi, Yayoi Matsuda, et al.. (2020). Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis. Bone. 133. 115221–115221. 12 indexed citations

13.

Yokomoto‐Umakoshi, Maki, Hironobu Umakoshi, Masatoshi Ogata, et al.. (2020). Coexistence of osteoporosis and atherosclerosis in pheochromocytoma: new insights into its long-term management. Osteoporosis International. 31(11). 2151–2160. 5 indexed citations

14.

Yokomoto‐Umakoshi, Maki, Hironobu Umakoshi, Ryuichi Sakamoto, et al.. (2020). Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma. Bone. 142. 115607–115607. 13 indexed citations

15.

Umakoshi, Hironobu, Ryuichi Sakamoto, Yayoi Matsuda, et al.. (2019). Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 105(4). 1284–1289. 17 indexed citations

16.

Yokomoto‐Umakoshi, Maki, Ryuichi Sakamoto, Hironobu Umakoshi, et al.. (2019). Unilateral primary aldosteronism as an independent risk factor for vertebral fracture. Clinical Endocrinology. 92(3). 206–213. 19 indexed citations

17.

Takuma, Yoshitaka, Kazuhiro Nouso, Yasuhiro Makino, et al.. (2007). Gastric ulcer after prophylactic balloon-occluded retrograde transvenous obliteration. Journal of Gastroenterology. 42(3). 257–260. 2 indexed citations

18.

Tanaka, Shouichi, et al.. (2006). POLYPOID COLONIC HAMARTOMATOUS INVERTED POLYP. Digestive Endoscopy. 19(1). 40–42. 2 indexed citations

19.

Sato, Kazutoshi & Masatoshi Ogata. (1995). [A patients with chronic renal failure due to Bartter's syndrome].. PubMed. 37(7). 404–9. 4 indexed citations

20.

Ogata, Masatoshi, Masato Ikeda, & Masanori Kuratsune. (1984). Mortality among Japanese Zen priests.. Journal of Epidemiology & Community Health. 38(2). 161–166. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact